Starting next week, Monday, October 19th, developers of human or veterinary medicines are instructed to use the European Medicines Agency’s (EMA) new IRIS Regulatory & Scientific Information Management Platform to request scientific advice.

The new system aims to provide a single space for applicants to submit requests, communicate, share information, and deliver documents concerning each scientific advice procedure.

Found here: the objective is that at any stage of a medicine’s development, the developer can ask for guidance and direction from EMA. This includes scientific advice for both human and veterinary, and also protocol assistance and qualification procedures for human medicines.

With a much easier route to obtaining information, the EMA is making solid strides in streamlining processes and reducing the overall time needed for applicants to prepare and submit applications for scientific procedures. It additionally ensures better data quality through integration with other EMA systems allowing users to check the status of their applications across multiple devices and receive automatic updates when their status changes.

Stay updated on all the industry news by following us on LinkedIn!

Additional News

  • 18 March 2024

    News from our newly opened clinic in Ostrava

    Our new Clinic in Ostrava (CZ) is gaining momentum step by step; therefore, we have some interesting news for you from the center of the action.

  • 19 December 2023

    Happy new year 2024

    As we bid farewell to 2023, it's time to express our deepest gratitude for the collaboration.

  • 4 December 2023

    Our new clinical unit in Ostrava comes to life

    It's a great pleasure to announce that after two years of hard work, the brand-new clinical unit in Ostrava with 36-beds capacity has been opened.